Status:

Red

Decision Date:

December 2024

Comments

RED: NICE TA1015: Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatment (Decision date December 2024)

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again